Contrast Media Market Size and Forecast 2024-2033|Bayer AG, GE Healthcare, Guerbet Group, Lantheus Medical Imaging Inc., Unijules Life Sciences Ltd

Overview and Scope

Contrast media refer to the chemical agents or contrast media that increase the contrast of structures of fluids in the body by improving the contrast resolution of an imaging modality. It is used to enhance and increase the quality of images (or pictures) that helps radiologist to report on how the body is functioning and whether there is any disease or anomaly.

Sizing and Forecast

The contrast media market size has grown steadily in recent years. It will grow from $4.51 billion in 2023 to $4.72 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to aging population and healthcare needs, expansion of radiology and imaging centers, rise in minimally invasive procedures, increasing incidence of cardiovascular diseases, globalization of healthcare services.

The contrast media market size is expected to see steady growth in the next few years. It will grow to $5.65 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to emergence of molecular imaging, expansion of diagnostic imaging modalities, personalized medicine approaches, global burden of cancer, expanding applications in neuroimaging, shift towards outpatient imaging services.. Major trends in the forecast period include advancements in imaging technologies, focus on patient safety and reduced nephrotoxicity, increasing utilization in interventional radiology, expanding applications in oncology imaging, introduction of low-osmolality contrast media, adoption of microbubbles in ultrasound imaging.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/contrast-media-global-market-report

Segmentation & Regional Insights

The contrast media market covered in this report is segmented –

1) By Type: Barium-Based Contrast Media, Iodinated Contrast Media, Gadolinium-Based Contrast Media, Microbubble Contrast Media

2) By Route of Administration: Intravascular Route, Oral Route, Rectal Route, Other Route of Administration

3) By Modality: X-Ray or CT, MRI, Ultrasound

4) By Indication: Cardiovascular Disease, Oncology, Gastrointestinal Disorders, Neurological Disorders, Other Indications

5) By End User: Hospitals, Clinics

North America was the largest region in the contrast media market in 2023. Asia-Pacific is expected to be the fastest-growing region in the contrast media market report during the forecast period. The regions covered in the contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7991&type=smp

Major Driver Impacting Market Growth

The increase in prevalence of long-term diseases and complex comorbidities is expected to propel the growth of the contrast media market going forward. Comorbidity refers to the presence of many diseases in one person at the same time. Contrast medium (CM) is a procedure used in imaging to emphasize the distinctions between human tissues in pictures. The optimal contrast medium produces extremely high concentrations in the tissues while causing no side effects, thus increasing the demand. For instance, in May 2022, according to Oxford Academic, a UK-based university press of the university of Oxford data, people with intellectual disabilities (ID), the occurrence of 2 or more comorbidities was higher before age 65, while for people without intellectual disabilities (ID) it has been highest after age 65. The most increased occurrence of 2 or more comorbidities in people with ID or Chronic obstructive pulmonary disease (COPD) occurred at ages 55–59. 17.6% of people with ID and CVD have been aged 60–64 years and had 2 or more comorbidities. Therefore, the increasing prevalence of long-term diseases and complex comorbidities are driving the growth of the contrast media market.

Key Industry Players

Major companies operating in the contrast media market report are Bayer AG, GE Healthcare, Guerbet Group, Lantheus Medical Imaging Inc., Unijules Life Sciences Ltd., J. B Chemicals and Pharmaceutical Ltd., Trivitron Healthcare Pvt. Ltd., Taejoon Pharm Co Ltd., Nano Therapeutics Pvt. Ltd., iMax Diagnostic Imaging Limited, Jodas Expoim Pvt Ltd., Livealth Biopharma Pvt. Ltd., SANOCHEMIA Pharmazeutika GmbH, Kiran Medical Systems Limited, Unispire Biopharma Private Limited, Daiichi Sankyo Company Limited, Bracco Diagnostics Inc., Jiangsu Hengrui Medicine Co. Ltd., Shanghai Xudong Haipu Pharmaceutical Co. Ltd., Spago Imaging AB, Curium Inc., Poly Pharmaceutical Co. Ltd., Zhejiang Starry Pharmaceutical Co. Ltd., Yangtze River Pharmaceutical Group, Wuhan Grand Hoyo Co. Ltd., China Resources Zizhu Pharmaceutical Co. Ltd., AMAG Pharmaceuticals Inc., Guerbet LLC

The contrast media market report table of contents includes:

1. Executive Summary

2. Contrast Media Market Characteristics

3. Contrast Media Market Trends And Strategies

4. Contrast Media Market – Macro Economic Scenario

5. Global Contrast Media Market Size and Growth

26. South America Contrast Media Market

27. Brazil Contrast Media Market

28. Middle East Contrast Media Market

29. Africa Contrast Media Market

30. Contrast Media Market Competitive Landscape And Company Profiles

Top Major Players: